Journal of Clinical Hepatology
This article studies the clinical characteristics and risk factors for liver cirrhosis in chronic hepatitis C virus (HCV) genotype 3 (GT3) patients in the northwestern region of China, aiming to fill the gap in related research in this area. The study found that compared with genotypes 1, 2, and 6, GT3 patients are mainly male, have a younger age of onset, a higher proportion of liver cirrhosis, and significantly higher levels of AST and ALT, lower platelet counts and Alb levels, and higher AFP, APRI, and FIB-4 indexes, indicating faster progression of liver inflammation and fibrosis. Multivariate analysis showed that low Alb levels and low platelet counts are independent risk factors for GT3 patients progressing to liver cirrhosis. In addition, the study emphasizes that GT3 has a poor response to DAA treatment, especially for GT3b subtypes with liver cirrhosis, with a significantly lower SVR rate, indicating that precise typing is of great clinical significance for optimizing treatment plans. The innovation lies in the first systematic evaluation of the epidemiology and clinical characteristics of GT3 patients in the northwestern region, combined with real-world data to explore the differences in treatment response, providing a basis for regionalized treatment strategies.
This study systematically analyzed the clinical characteristics and risk factors for liver cirrhosis progression in chronic hepatitis C (CHC) genotype 3 (GT3) patients in the northwestern region of China, which has important clinical and public health significance. The study found that GT3 patients are mainly male, have an earlier age of onset than GT1 and GT2, and a higher proportion of liver cirrhosis, with more significant liver inflammation and fibrosis, indicating faster disease progression. Especially in patients with liver cirrhosis, the average age of GT3 is significantly lower than that of other genotypes, indicating its early onset and severity. Multivariate analysis showed that platelet count ≤150×10⁹/L and albumin ≤35 g/L are independent risk factors for GT3 patients progressing to liver cirrhosis, providing reliable indicators for early identification of high-risk populations in clinical settings. In addition, the study emphasizes that GT3 is closely related to adverse lifestyle habits (such as smoking, IDU), indicating that prevention and control need to be combined with social behavior intervention. This multicenter retrospective study provides an important basis for the individualized management and intervention strategies for GT3 hepatitis C in our country.
Objective: To investigate the clinical features of chronic hepatitis C(CHC) patients with hepatitis C virus genotype 3...
